Orthofix International recently announced that Kevin L unger has been appointed as president of the company’s spinal implants division. He will report directly to Brad Mason, who was previously named Group President of North America and has been serving as the President of Orthofix Spinal Implants since September of last year.
Unger joins Orthofix after more than 14 years with Stryker Corporation, where he served the last five years as a Vice President and General Manager in the MedSurg Division. While with Stryker, he held roles with increasing responsibility in marketing and sales, during which he built sales organisations, was head of a global marketing department and led business development initiatives. He helped create a MedSurg business which grew from $30 million dollars to $200 million dollars under his leadership.
“We are excited to welcome Kevin to Orthofix, and believe his many years of experience in the global medical device industry will enable us to continue the progress we have made within Orthofix Spinal Implants over the last few quarters,” said Alan Milinazzo, president and CEO of Orthofix International. “Additionally and very importantly, Kevin has a strong track record of driving superb financial results on a consistent basis.”
Orthofix recently reported second quarter financial results which included a strong performance in the spinal implants division with growth of 12 percent over the prior year. Also, the Company recently reported the successful full market release of Trinity Evolution, the next generation adult stem cell-based allograft that has generated significant interest from both spine and orthopaedic surgeons.
